FDA approves new Botox warning

The FDA recently announced that it approved a new warning on Allergan Inc.’s Botox about the possibility of life-threatening breathing or swallowing problems. The FDA also said that it is changing the generic names for Botox to avoid medication errors.

To read more about the FDA warning approval.

Lawyer Monthly - Legal Awards Winner
The National Trial Lawyers
Elder Care Matters Alliance
American Association for Justice
Fellow Litigation Counsel of America
Super Lawyers